HERANOVA Trademark
Trademark Overview
On Thursday, October 31, 2024, a trademark application was filed for HERANOVA with the United States Patent and Trademark Office. The USPTO has given the HERANOVA trademark a serial number of 98831068. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Tuesday, June 9, 2026. This trademark is owned by Heranova Lifesciences Inc.. The HERANOVA trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical devices, namely, surgical and nonsurgical devices for treating endometriosis, infertility, and gynecological diseases and disorders.
Providing medical information in the field of gynecology; medical information services in the gynecological field; medical testing services for diagnostic purposes in the field of gynecology, namely, testing services for detecting endometritis, a woman's personalized embryo implantation time, and/or Pelvic Inflammatory Disease and antibiotic resistance either post-partum or in cases of unexplained infertility; medical diagnostic services for gynecological diseases and disorders, namely, for detecting endometriosis by identifying and analyzing biomarkers for diagnostic and/or treatment purposes; medical assessment services, namely, health assessment of a patient's remaining childbearing years based on patient-specific health information.
Medical diagnostic assays for testing for the presence of biomarkers in blood or bodily fluids for diagnosing gynecological diseases, namely endometriosis; Medical diagnostic assays for testing for the presence of biomarkers in uterine tissue for determining a patient's personalized and optimal embryo implantation time and for determining a patient's personalized treatment plan, as well as the composition of microbiome, including presence of normal lactobacillus and targeted pathogenic bacteria, namely, Escherichia, Klebsiella, Enterococcus, Streptococcus, Mycoplasma, Chlamydia, Ureaplasma, Neisseria, Staphylococcus, and Gardnerella; Medical diagnostic assays for testing for the presence of biomarkers in uterine and vaginal tissue for determining a patient's personalized treatment plan; for bacterial, fungal and resistance markers for determining a personalized treatment plan; Medical diagnostic assays for testing for the presence of biomarkers in human biological material for diagnosi...
General Information
| Serial Number | 98831068 |
| Word Mark | HERANOVA |
| Filing Date | Thursday, October 31, 2024 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Tuesday, June 9, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 8, 2025 |
Trademark Statements
| Goods and Services | Medical devices, namely, surgical and nonsurgical devices for treating endometriosis, infertility, and gynecological diseases and disorders. |
| Goods and Services | Providing medical information in the field of gynecology; medical information services in the gynecological field; medical testing services for diagnostic purposes in the field of gynecology, namely, testing services for detecting endometritis, a woman's personalized embryo implantation time, and/or Pelvic Inflammatory Disease and antibiotic resistance either post-partum or in cases of unexplained infertility; medical diagnostic services for gynecological diseases and disorders, namely, for detecting endometriosis by identifying and analyzing biomarkers for diagnostic and/or treatment purposes; medical assessment services, namely, health assessment of a patient's remaining childbearing years based on patient-specific health information. |
| Goods and Services | Medical diagnostic assays for testing for the presence of biomarkers in blood or bodily fluids for diagnosing gynecological diseases, namely endometriosis; Medical diagnostic assays for testing for the presence of biomarkers in uterine tissue for determining a patient's personalized and optimal embryo implantation time and for determining a patient's personalized treatment plan, as well as the composition of microbiome, including presence of normal lactobacillus and targeted pathogenic bacteria, namely, Escherichia, Klebsiella, Enterococcus, Streptococcus, Mycoplasma, Chlamydia, Ureaplasma, Neisseria, Staphylococcus, and Gardnerella; Medical diagnostic assays for testing for the presence of biomarkers in uterine and vaginal tissue for determining a patient's personalized treatment plan; for bacterial, fungal and resistance markers for determining a personalized treatment plan; Medical diagnostic assays for testing for the presence of biomarkers in human biological material for diagnosing gynecological diseases, namely, primary ovarian insufficiency; Pharmaceuticals, namely, therapeutic drugs for treating endometriosis, infertility, and gynecological diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, December 8, 2025 |
| First Use In Commerce Date | Monday, December 8, 2025 |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | Monday, December 8, 2025 |
| First Use In Commerce Date | Monday, December 8, 2025 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | Monday, December 8, 2025 |
| First Use In Commerce Date | Monday, December 8, 2025 |
Trademark Owner History
| Party Name | Heranova Lifesciences Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Burlington, MA 01803
US |
| Party Name | Heranova Lifesciences Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Burlington, MA 01803
US |
Trademark Events
| Event Date | Event Description |
| Thursday, October 31, 2024 | NEW APPLICATION ENTERED |
| Sunday, May 4, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 5, 2025 | ASSIGNED TO EXAMINER |
| Thursday, May 8, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, May 8, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, May 8, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 2, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, June 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 3, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 2, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 8, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 8, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 2, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, March 2, 2026 | TEAS STATEMENT OF USE RECEIVED |
| Monday, March 2, 2026 | USE AMENDMENT FILED |
| Tuesday, June 9, 2026 | STATEMENT OF USE PROCESSING COMPLETE |
